From what I have been told, most rx shops will get you a shot at distressed funds. Seconding QdjustedEBITDAD's question as would love to hear perspectives from people who have worked at these shops.

 

Bump — anyone know if exits to standard corporate MF PE (BX, KKR, APO, etc) are still available from RX at these shops as well or would you get overlooked for a T1 kid? I’ve seen conflicting advice about how HC at either of these shops (very strong at both) might have stronger exits than RX. Could be BS though

 

CVP operates on a generalist model at the analyst level, but traditionally analysts who have spent their time mostly focusing on RX have exited quite well (historical exits include Crestview, Centerbridge, Blackstone TacOpps). PWP's RX group is probably their strongest group in terms of exits and place well (historical exits include Apollo, KKR, Blackstone, Diameter, Oaktree)

 

Do you have any idea if they can keep it up?/is their RX team on the up and up? Haven’t heard much about them since the Kramer incident

 
Most Helpful

This is a pretty tired point. Kramer and his team left 7 years ago. They have rebuilt and have a smaller team compared to PJT/HL/EVR and are more selective with mandates they pick up for this reason (pursue high fee). That’s a firm wide theme as well with M&A. They had the largest bankruptcy in 2019 with iHeart and now the largest in recent history with FTX. TPH offered them a lot of O&G opportunities and you’ll see them in healthcare a lot due to the strength of that team at the firm. Also I believe on bed bath creditor side and Celsius at the moment.

 

The Kramer situation is long in the past. They are the debtor side for FTX, Clovis, 1L Advisors for Endo and Valaris, and Celsius/Cineworld UCC... These are the ones that immediately come to mind. They were also creditor side for participating lenders on Mitel's Uptier, the creditor side with BBBY(I think they are still creditor side for the BK).

Unfortunately, many RX transactions just aren't going to be public knowledge. But they are a good team. The biggest differentiator between PJT/EVR/HL/MOE/LAZ relative to PWP/CVP type shops is the volume of transactions. PWP/CVP just don't have the same volume relative to the other groups.

 

Explicabo non sint distinctio cupiditate. Quis et explicabo dignissimos fuga in repellat iste.

Career Advancement Opportunities

May 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. New 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 04 97.1%

Overall Employee Satisfaction

May 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

May 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

May 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (20) $385
  • Associates (88) $260
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (67) $168
  • 1st Year Analyst (205) $159
  • Intern/Summer Analyst (146) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Betsy Massar's picture
Betsy Massar
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
Secyh62's picture
Secyh62
99.0
5
dosk17's picture
dosk17
98.9
6
CompBanker's picture
CompBanker
98.9
7
kanon's picture
kanon
98.9
8
GameTheory's picture
GameTheory
98.9
9
Linda Abraham's picture
Linda Abraham
98.8
10
numi's picture
numi
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”